GenMark Diagnostics (GNMK) Likely to Report 'Material' Revenue Upside - Cowen

June 19, 2020 7:37 AM EDT Send to a Friend
Cowen analyst Doug Schenkel reiterated an Outperform rating and highlighted GenMark Diagnostics (NASDAQ: GNMK) as one of the Best Small ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login